Document is current
Any future updates will be listed below
-
Authors
Dubey, Shirish https://orcid.org/0000-0002-9979-6066
Peddasomayajulu, Abhinav https://orcid.org/0009-0009-2758-1187
Nandagudi, Anupama https://orcid.org/0000-0003-2035-8395
Maw, WinWin
Makkuni, Damodar
Banerjee, Siwalik
Koduri, Gouri M. https://orcid.org/0000-0003-4189-703X
- License Information
-
More Information
Article History
Received: 10 June 2025
Accepted: 29 August 2025
First Online: 24 September 2025
Declarations
:
: Ethical approval was obtained for this study (IRAS 319483, REC reference number is 22/EE/0303), dated 17th Feb 2023, from Health Research Authority and Health and Care Wales. Patients were approached face to face when attending rheumatology department for any reason. They were provided the information for the study and then approached by the research team. Patients were identified from database from one of the centres and consent form and information about the study was posted. Patients then submitted signed consent form and filled questionnaire either as part of visit to hospital, or email or via post. All study participants provided written consent. The study was performed in keeping with the good clinical practice in research as per the Helsinki agreement.
: SD: Advisory Board: Boehringer Ingelheim and Abbvie. GK: Advisory Board: BI, speaker honorarium Roche, BI, Medac, support for conference attendance Medac. None of these disclosures cause any conflict with this work. Disclosure form submitted as well. No editing agencies or AI were utilized within this study or for this manuscript.
